Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.
about
L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa historyAdenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson diseaseDopamine-dependent motor learning: insight into levodopa's long-duration response.Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's diseaseUsing caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian miceNigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic outputChronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark miceSerotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degenerationImpaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.Parkinson's disease: genetic versus toxin-induced rodent models.Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient miceStriatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice.Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.Animal models of L-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse.
P2860
Q28602694-DAB4E706-F0BD-4A10-BEB4-B7BD5381981AQ29346490-FA092DB2-5C0E-4EAA-B549-F07852D2CEC2Q30502109-73C8CD01-1A96-4AC9-8688-651E9E812751Q30538394-5A1D6AD8-71C8-4AB7-91F0-02C9CDDB0F57Q33577182-953BDCB7-8F9A-498A-8D02-827E793C85A0Q33971113-830FDAD3-7F19-4BBA-B35F-4D19EBA49A6CQ34490801-FA9981CC-18C6-4FFC-AC41-6283FA7C84F7Q35178497-432B8154-CD91-49CE-8636-5E561211C16EQ35509519-5DF21B01-6F69-4BAA-841D-2DD60C7C39D5Q36680671-4CA6498E-0485-4FC5-8647-78E2D645E1CCQ36691830-4E5DB078-E3BA-4B56-ABAF-499AC91BB5F3Q36996302-997710E1-9332-4CDB-B5FD-9A471AB66B3DQ37086124-B9DD05E7-4630-44E2-9772-BDCA48D4C7F0Q37346328-EEE2471D-9A83-45F5-8F09-25CC6DA804BDQ37597274-A4F8D216-25EB-4CEF-A0B1-975D7EC3BD64Q47876389-566FF923-7970-4A42-BEF5-3AC5E0F15281Q48113961-ADB26B07-C7A2-481F-966F-34B2044C1820
P2860
Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@ast
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@en
type
label
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@ast
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@en
prefLabel
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@ast
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@en
P2093
P2860
P921
P1476
Chronic 3,4-dihydroxyphenylala ...... model of Parkinson's disease.
@en
P2093
Dong-Youn Hwang
Jacqueline Restrepo
Kwang-Soo Kim
Un Jung Kang
Yunmin Ding
P2860
P356
10.1016/J.NBD.2007.03.013
P577
2007-04-10T00:00:00Z